PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 108 filers reported holding PROVENTION BIO INC in Q4 2020. The put-call ratio across all filers is 3.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $657,183 | +467.3% | 27,269 | +148.8% | 0.00% | – |
| Q4 2022 | $115,847 | -99.9% | 10,960 | -49.1% | 0.00% | – |
| Q3 2022 | $96,826,000 | +45.1% | 21,517 | +29.0% | 0.00% | – |
| Q2 2022 | $66,708,000 | +65.3% | 16,677 | +202.6% | 0.00% | – |
| Q1 2022 | $40,348,000 | -62.8% | 5,512 | -71.4% | 0.00% | – |
| Q4 2021 | $108,370,000 | +29.3% | 19,283 | +47.3% | 0.00% | – |
| Q3 2021 | $83,789,000 | +45.9% | 13,092 | +92.1% | 0.00% | – |
| Q2 2021 | $57,442,000 | -20.1% | 6,814 | -0.5% | 0.00% | – |
| Q1 2021 | $71,880,000 | -53.7% | 6,849 | -25.2% | 0.00% | – |
| Q4 2020 | $155,187,000 | +8.4% | 9,161 | -17.9% | 0.00% | – |
| Q3 2020 | $143,119,000 | +529.6% | 11,155 | +592.4% | 0.00% | – |
| Q2 2020 | $22,731,000 | – | 1,611 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 886,662 | $15,020,000 | 3.18% |
| Perceptive Advisors | 4,224,389 | $71,561,000 | 0.77% |
| 683 Capital Management, LLC | 859,314 | $14,557,000 | 0.69% |
| Soleus Capital Management, L.P. | 105,941 | $1,795,000 | 0.24% |
| GILDER GAGNON HOWE & CO LLC | 2,359,682 | $39,973,000 | 0.20% |
| RICE HALL JAMES & ASSOCIATES, LLC | 247,116 | $4,186,000 | 0.15% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 23,127 | $392,000 | 0.12% |
| Virtus ETF Advisers LLC | 15,878 | $269,000 | 0.11% |
| Newbridge Financial Services Group, Inc. | 6,500 | $110,000 | 0.09% |
| Windsor Creek Advisors, LLC | 18,000 | $305,000 | 0.08% |